Structure of Ethyl 4-hydroxyquinoline-3-carboxylate CAS 26892-90-0

Ethyl 4-hydroxyquinoline-3-carboxylate CAS 26892-90-0

/in , , /by

Identification

CAS Number

26892-90-0

Name

Ethyl 4-hydroxyquinoline-3-carboxylate

Synonyms

1H-Benzimidazole, 2-(4-piperidinyl)- [ACD/Index Name]
2-(4-Piperidinyl)-1H-benzimidazol [German] [ACD/IUPAC Name]
2-(4-Piperidinyl)-1H-benzimidazole [ACD/IUPAC Name]
2-(4-Pipéridinyl)-1H-benzimidazole [French] [ACD/IUPAC Name]
2-(piperidin-4-yl)-1H-benzimidazole
2-piperidin-4-yl-1H-benzimidazole
38385-95-4 [RN]
[38385-95-4]
1006463-47-3 [RN]
1H-Benzimidazole,2-(4-piperidinyl)-
1H-Benzoimidazole, 2-(piperidin-4-yl)-
2-​piperidin-​4-​yl-​1h-​benzimidazole
2-(4-Piperidinyl)-1H-Benzimidazole (en)
2-(4-piperidinyl)benzimidazole
2-(4-Piperidyl)-1H-1,3-benzimidazole
2-(4-Piperidyl)-1H-benzoimidazole
2-(4-Piperidyl)-1H-benzoimidazole?
2-(4-piperidyl)benzimidazole
2-(piperidin-4-yl)-1H-1,3-benzodiazole
2-(piperidin-4-yl)-1h-benzo[d]imidazole
2-(Piperidin-4-yl)-1Hbenzo[d]imidazole
2-???piperidin-???4-???yl-???1h-???benzimidazole
26892-90-0 [RN]
2-piperidin-4-yl-1{H}-benzimidazole
2-Piperidin-4-yl-1H-benzoimidazole
38702-18-0 [RN]
3-ethoxy-2,2-dimethyl-3-oxopropanoic acid;Dimethylmalonic Acid Monoethyl Ester
41253-01-4 [RN]
Benzoic acid, 4-(aminomethyl)- (9CI)
bilastine its-4
BR-34949
FS-3052
HBOGHPAOOWUTLB-UHFFFAOYSA-N
http:////www.amadischem.com/proen/586446/
http://en.atomaxchem.com/38385-95-4.html
PI-45085
ST-5596

SMILES

c1ccc2c(c1)[nH]c(n2)C3CCNCC3

StdInChI

InChI=1S/C12H15N3/c1-2-4-11-10(3-1)14-12(15-11)9-5-7-13-8-6-9/h1-4,9,13H,5-8H2,(H,14,15)

StdInChIKey

HBOGHPAOOWUTLB-UHFFFAOYSA-N

Molecular Formula

C12H15N3

Molecular Weight

201.268

MDL Number

MFCD00173406

Properties

Appearance

Off white powder

Safety Data

WGK Germany

3

Specifications and Other Information of Our Ethyl 4-hydroxyquinoline-3-carboxylate CAS 26892-90-0

Identification Methods

HNMR, HPLC

Purity

98% min

Shelf Life

2 years

Storage

Under room temperature away from light

Known Application

Used as pharmaceutical intermediates.

This product is developed by our R&D company Caming Pharmaceutical Ltd (https://www.caming.com/).

This product is developed by our R&D company Watson International Ltd (https://www.watson-int.com/).